Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL – Get Free Report) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 1,100 shares, a decrease of 57.7% from the November 15th total of 2,600 shares. Based on an average trading volume of 300 shares, the days-to-cover ratio is presently 3.7 days.
Tema Neuroscience and Mental Health ETF Price Performance
MNTL stock traded down $0.63 on Thursday, hitting $25.07. 99 shares of the company were exchanged, compared to its average volume of 12,321. The stock has a market capitalization of $11.03 million, a price-to-earnings ratio of 25.24 and a beta of 0.99. Tema Neuroscience and Mental Health ETF has a twelve month low of $23.67 and a twelve month high of $27.66. The business’s fifty day moving average is $26.28 and its two-hundred day moving average is $26.25.
Tema Neuroscience and Mental Health ETF Dividend Announcement
The company also recently disclosed a dividend, which will be paid on Thursday, December 12th. Stockholders of record on Wednesday, December 11th will be issued a dividend of $0.257 per share. The ex-dividend date is Wednesday, December 11th.
Tema Neuroscience and Mental Health ETF Company Profile
The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Further Reading
- Five stocks we like better than Tema Neuroscience and Mental Health ETF
- Top Stocks Investing in 5G Technology
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- 3 REITs to Buy and Hold for the Long Term
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Compound Interest and Why It Matters When Investing
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Tema Neuroscience and Mental Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.